 |
市場調查報告書
商品編碼
1550536
製藥業人工智慧 (AI) 的全球市場：按部署模式、按交付、按技術、按藥物類型、按應用、按最終用戶、按地區Global Artificial Intelligence In Pharmaceutical Market, By Deployment Mode, By Offering, By Technology, By Drug Type, By Application, By End User, By Geography |
||||||
價格
簡介目錄
預計2024年全球人工智慧（AI）在藥品領域的市場規模為11.081億美元，2024年至2031年複合年成長率為32.1%，2031年將達到77.762億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 11.081 億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 32.10% | 2031年價值預測 | 77.762 億美元 |
圖：2024 年按地區分類的人工智慧 (AI)全球市場佔有率(%)
人工智慧 (AI) 已成為一項變革性技術，將徹底改變製藥業。透過利用大量資料和先進演算法，人工智慧有潛力幫助藥品製造商加速藥物發現、簡化臨床試驗並實現更準確的診斷和治療。人工智慧透過快速分析大量資料集並識別可能導致新治療方法的關係，有力地支持了藥物科學家的工作。利用人工智慧，研究人員可以以前所未有的規模和速度分析基因序列資訊和電子健康記錄。這項技術可以幫助發現新的治療方法並預測重新利用現有藥物治療其他疾病的潛力。人工智慧可望增強人類能力，提高藥物研發效率，更快為病患帶來創新藥物。
市場動態：
降低藥物發現和開發成本、縮短藥物開發週期和推動精準醫療的需求日益成長，推動了全球製藥業人工智慧 (AI) 市場的成長。人工智慧可以加速藥物發現，減少昂貴的後期臨床試驗的失敗，並幫助藥物更快推向市場。然而，人工智慧模型缺乏可解釋性以及對其融入決策的懷疑可能會阻礙其採用。增加藥物資料集的可用性和加強法律規範可以提供重大的成長機會。如果處理得當，可以克服可解釋性問題和缺乏專業知識，並實現這種變革性技術的全部潛力。
本研究的主要特點
- 這份報告對全球製藥人工智慧（AI）市場進行了詳細分析，並提供了我以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。 。
- 它闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
- 它根據公司亮點、產品系列、主要亮點、財務業績和策略等參數，介紹了全球製藥市場人工智慧 (AI)的主要企業。
- 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
- 全球製藥市場人工智慧 (AI) 報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 相關人員可以透過分析全球製藥人工智慧 (AI) 市場時使用的各種策略矩陣來促進決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第 4 章：全球製藥人工智慧 (AI) 市場 - 新型冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球製藥人工智慧（AI）市場：按部署類型（2019-2031）
- 雲
- 本地
第6章 全球製藥人工智慧 (AI) 市場：依產品分類（2019-2031）
- 硬體
- 軟體
- 服務
第7章 全球製藥人工智慧 (AI) 市場：依技術分類（2019-2031）
- 自然語言處理
- 情境感知處理
- 深度學習
- 查詢研究方法
- 其他
第8章全球醫藥人工智慧（AI）市場：依藥品類型分類（2019-2031）
- 高分子
- 小分子
第9章全球醫藥人工智慧（AI）市場：依應用分類（2019-2031）
- 藥物發現
- 臨床試驗
- 研究與開發
- 藥品製造及供應鏈
- 其他
第10章全球製藥人工智慧（AI）市場：依最終用戶分類（2019-2031）
- 製藥和生物技術公司
- 醫院和診斷中心
- 學術研究所
- 其他
第11章全球製藥人工智慧（AI）市場：按地區（2019-2031）
- 拉丁美洲
- 歐洲
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第12章競爭格局
- 公司簡介
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
第13章分析師建議
- Wheel of Fortune
- 分析師觀點
- Coherent Opportunity Map（COM）
第14章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI7209
Global artificial intelligence (AI) in pharmaceutical market is estimated to be valued at USD 1,108.1 Mn in 2024 and is expected to reach USD 7,776.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 32.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1,108.1 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 32.10% | 2031 Value Projection: | US$ 7,776.2 Mn |
Figure. Global Artificial Intelligence (AI) In Pharmaceutical Market Share (%), By Region 2024
Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery, streamline clinical trials and enable more precise diagnosis and treatment. AI augments the work of pharmaceutical scientists by swiftly analyzing huge datasets to identify relationships that may lead to new therapies. With AI, researchers can analyze genetic sequencing information or electronic health records at an unprecedented scale and speed. The technology helps discover new therapies and predict which existing drugs could be repurposed to treat other conditions. AI promises to augment human capabilities, make pharmaceutical R&D more efficient and bring innovative new medicines to patients faster.
Market Dynamics:
Global artificial intelligence (AI) in pharmaceutical market growth is driven by rising need to control drug discovery and development costs, reduce the drug development cycle time and advance precision medicine. AI can accelerate drug discovery, reduce expensive late-stage clinical trial failures and help launch drugs faster. However, lack of interpretability of AI models and skepticism about integrating it into decision-making can hamper its adoption. Growing availability of pharma data sets and encouraging regulatory frameworks can offer significant growth opportunities. If addressed properly, interpretability issues and lack of expertise can be overcome to extract full potential from this transformative technology.
Key Features of the Study:
- This report provides in-depth analysis of the global artificial intelligence (AI) in pharmaceutical market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial intelligence (AI) in pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IBM, Microsoft, AWS, Google, Anthropic, Berg Health and InSilico Medicine
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global artificial intelligence (AI) in pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) in pharmaceutical market
Detailed Segmentation-
- By Deployment Mode
- Cloud
- On-Premise
- By Offering
- Hardware
- Software
- Services
- By Technology
- Natural Language Processing
- Context-Aware Processing
- Deep Learning
- Querying Method
- Other
- By Drug Type
- Large Molecules
- Small Molecules
- By Application
- Drug Discovery
- Clinical Trial
- Research & Development
- Drug Manufacturing and Supply Chain
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostic Centers
- Academic & Research Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Deployment Mode
- Market Snapshot, By Offering
- Market Snapshot, By Technology
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Artificial Intelligence (AI) in Pharmaceutical Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Deployment Mode, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cloud
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- On-Premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Offering, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hardware
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Software
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Services
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Technology, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Natural Language Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Context-Aware Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Deep Learning
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Querying Method
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Drug Type, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Application, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Clinical Trial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Research & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Drug Manufacturing and Supply Chain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
10. Global Artificial Intelligence (AI) in Pharmaceutical Market, By End User, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Hospitals and Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
11. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Company Profiles
- NVIDIA Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
- NVIDIA Corporation
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
